ORKA
Oruka Therapeutics, Inc.
+0.98 (+1.05%)94.53USD183K成交股數6.3B市值21.3本益比(近四季)–股價營收比–營收年增(近四季)2026-11-11下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 51 · 1.5B · 10 |
| 其中 10b5-1 計畫賣出 | 43 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 1.5B |
| 近 180 天 淨額 | −1.5B |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-15 | 09-15 | Goncalves Joana | Chief Medical Officer | S 公開市場賣出(10b5-1) | 1.4K | 92.99 | 127K | 32.8K | SEC |
| 2026-09-15 | 09-15 | Goncalves Joana | Chief Medical Officer | S 公開市場賣出(10b5-1) | 100 | 94.22 | 9K | 32.7K | SEC |
| 2026-09-15 | 09-15 | Goncalves Joana | Chief Medical Officer | S 公開市場賣出(10b5-1) | 3.1K | 92.03 | 290K | 34.2K | SEC |
| 2026-09-15 | 09-15 | Goncalves Joana | Chief Medical Officer | S 公開市場賣出(10b5-1) | 947 | 95.71 | 91K | 31.8K | SEC |
| 2026-09-15 | 09-15 | Goncalves Joana | Chief Medical Officer | M 選擇權執行 | 3.5K | 6.84 | 24K | 36.2K | SEC |
| 2026-09-15 | 09-15 | Quinlan Paul T | General Counsel | S 公開市場賣出 | 1.0K | 95.71 | 99K | 30.0K | SEC |
| 2026-09-15 | 09-15 | Goncalves Joana | Chief Medical Officer | M 選擇權執行 | 3.5K | 7.80 | 27K | 39.7K | SEC |
| 2026-09-15 | 09-15 | Goncalves Joana | Chief Medical Officer | S 公開市場賣出(10b5-1) | 2.4K | 91.10 | 217K | 37.3K | SEC |
| 2026-09-15 | 09-15 | Klein Lawrence Otto | Chief Executive Officer | S 公開市場賣出 | 2.5K | 95.71 | 235K | 923K | SEC |
| 2026-09-15 | 09-15 | Sandler Laura Lee | Chief Operating Officer | S 公開市場賣出 | 906 | 95.71 | 87K | 235K | SEC |
| 2026-09-15 | 09-15 | Agarwal Arjun | Senior Vice President, Finance | S 公開市場賣出(10b5-1) | 560 | 95.71 | 54K | 14.8K | SEC |
| 2026-09-11 | 09-15 | Agarwal Arjun | Senior Vice President, Finance | S 公開市場賣出(10b5-1) | 2.2K | 93.26 | 206K | 15.5K | SEC |
| 2026-09-11 | 09-15 | Agarwal Arjun | Senior Vice President, Finance | S 公開市場賣出(10b5-1) | 4.1K | 92.41 | 374K | 17.7K | SEC |
| 2026-09-11 | 09-15 | Agarwal Arjun | Senior Vice President, Finance | S 公開市場賣出(10b5-1) | 3.0K | 91.11 | 273K | 21.8K | SEC |
| 2026-09-11 | 09-15 | Agarwal Arjun | Senior Vice President, Finance | M 選擇權執行 | 1.5K | 34.39 | 50K | 24.8K | SEC |
| 2026-09-11 | 09-15 | Agarwal Arjun | Senior Vice President, Finance | M 選擇權執行 | 8.0K | 12.50 | 100K | 23.3K | SEC |
| 2026-09-11 | 09-15 | Agarwal Arjun | Senior Vice President, Finance | S 公開市場賣出(10b5-1) | 200 | 94.02 | 19K | 15.3K | SEC |
| 2026-09-01 | 09-01 | Klein Lawrence Otto | Chief Executive Officer | M 選擇權執行 | 75.0K | 7.80 | 585K | 1.0M | SEC |
| 2026-09-01 | 09-01 | Sandler Laura Lee | Chief Operating Officer | S 公開市場賣出(10b5-1) | 4.0K | 92.01 | 368K | 236K | SEC |
| 2026-09-01 | 09-01 | Klein Lawrence Otto | Chief Executive Officer | S 公開市場賣出(10b5-1) | 6.6K | 90.79 | 600K | 994K | SEC |
| 2026-09-01 | 09-01 | Klein Lawrence Otto | Chief Executive Officer | S 公開市場賣出(10b5-1) | 63.6K | 91.90 | 5.8M | 930K | SEC |
| 2026-09-01 | 09-01 | Sandler Laura Lee | Chief Operating Officer | M 選擇權執行 | 5.0K | 7.80 | 39K | 241K | SEC |
| 2026-09-01 | 09-01 | Sandler Laura Lee | Chief Operating Officer | S 公開市場賣出(10b5-1) | 1.0K | 91.05 | 91K | 240K | SEC |
| 2026-09-01 | 09-01 | Klein Lawrence Otto | Chief Executive Officer | S 公開市場賣出(10b5-1) | 4.8K | 92.44 | 444K | 926K | SEC |
| 2026-08-24 | 08-25 | Edwards Larry Todd | Chief Commercial Officer | A 獲配股票 | 100K | – | – | 100K | SEC |
| 2026-08-17 | 08-17 | Goncalves Joana | Chief Medical Officer | S 公開市場賣出(10b5-1) | 2.5K | 112.56 | 279K | 32.7K | SEC |
| 2026-08-17 | 08-17 | Goncalves Joana | Chief Medical Officer | S 公開市場賣出(10b5-1) | 3.3K | 112.01 | 372K | 35.2K | SEC |
| 2026-08-17 | 08-17 | Goncalves Joana | Chief Medical Officer | S 公開市場賣出(10b5-1) | 300 | 110.52 | 33K | 38.5K | SEC |
| 2026-08-17 | 08-17 | Goncalves Joana | Chief Medical Officer | S 公開市場賣出(10b5-1) | 900 | 109.65 | 99K | 38.8K | SEC |
| 2026-08-17 | 08-17 | Goncalves Joana | Chief Medical Officer | M 選擇權執行 | 3.5K | 7.80 | 27K | 39.7K | SEC |
| 2026-08-17 | 08-17 | Goncalves Joana | Chief Medical Officer | M 選擇權執行 | 3.5K | 6.84 | 24K | 36.2K | SEC |
| 2026-08-14 | 08-14 | Quinlan Paul T | General Counsel | S 公開市場賣出(10b5-1) | 10.2K | 109.11 | 1.1M | 44.1K | SEC |
| 2026-08-14 | 08-14 | Quinlan Paul T | General Counsel | S 公開市場賣出(10b5-1) | 9.2K | 110.00 | 1.0M | 34.9K | SEC |
| 2026-08-14 | 08-14 | Quinlan Paul T | General Counsel | M 選擇權執行 | 42.0K | 12.50 | 525K | 83.0K | SEC |
| 2026-08-14 | 08-14 | Quinlan Paul T | General Counsel | S 公開市場賣出(10b5-1) | 10.4K | 107.14 | 1.1M | 69.0K | SEC |
| 2026-08-14 | 08-14 | Quinlan Paul T | General Counsel | S 公開市場賣出(10b5-1) | 3.6K | 106.05 | 385K | 79.4K | SEC |
| 2026-08-14 | 08-14 | Quinlan Paul T | General Counsel | M 選擇權執行 | 10.0K | 7.80 | 78K | 41.0K | SEC |
| 2026-08-14 | 08-14 | Quinlan Paul T | General Counsel | S 公開市場賣出(10b5-1) | 3.8K | 111.14 | 428K | 31.0K | SEC |
| 2026-08-14 | 08-14 | Quinlan Paul T | General Counsel | S 公開市場賣出(10b5-1) | 14.7K | 107.97 | 1.6M | 54.3K | SEC |
| 2026-08-13 | 08-14 | Agarwal Arjun | Senior Vice President, Finance | M 選擇權執行 | 1.5K | 34.39 | 50K | 25.3K | SEC |
| 2026-08-13 | 08-14 | Agarwal Arjun | Senior Vice President, Finance | S 公開市場賣出(10b5-1) | 2.4K | 108.46 | 256K | 15.3K | SEC |
| 2026-08-13 | 08-14 | Agarwal Arjun | Senior Vice President, Finance | S 公開市場賣出(10b5-1) | 1.3K | 106.63 | 135K | 19.8K | SEC |
| 2026-08-13 | 08-14 | Agarwal Arjun | Senior Vice President, Finance | S 公開市場賣出(10b5-1) | 2.1K | 107.71 | 231K | 17.7K | SEC |
| 2026-08-13 | 08-14 | Agarwal Arjun | Senior Vice President, Finance | S 公開市場賣出(10b5-1) | 2.1K | 104.67 | 220K | 23.2K | SEC |
| 2026-08-13 | 08-14 | Agarwal Arjun | Senior Vice President, Finance | M 選擇權執行 | 8.5K | 12.50 | 107K | 23.9K | SEC |
| 2026-08-13 | 08-14 | Agarwal Arjun | Senior Vice President, Finance | S 公開市場賣出(10b5-1) | 2.1K | 105.57 | 225K | 21.1K | SEC |
| 2026-07-15 | 07-15 | Goncalves Joana | Chief Medical Officer | S 公開市場賣出(10b5-1) | 400 | 84.37 | 34K | 39.3K | SEC |
| 2026-07-15 | 07-15 | Goncalves Joana | Chief Medical Officer | M 選擇權執行 | 3.5K | 7.80 | 27K | 39.7K | SEC |
| 2026-07-15 | 07-15 | Goncalves Joana | Chief Medical Officer | S 公開市場賣出(10b5-1) | 300 | 87.25 | 26K | 32.7K | SEC |
| 2026-07-15 | 07-15 | Goncalves Joana | Chief Medical Officer | M 選擇權執行 | 3.5K | 6.84 | 24K | 36.2K | SEC |
| 2026-07-15 | 07-15 | Goncalves Joana | Chief Medical Officer | S 公開市場賣出(10b5-1) | 3.8K | 86.68 | 330K | 33.0K | SEC |
| 2026-07-15 | 07-15 | Goncalves Joana | Chief Medical Officer | S 公開市場賣出(10b5-1) | 2.5K | 85.86 | 214K | 36.8K | SEC |
| 2026-07-13 | 07-13 | Agarwal Arjun | Senior Vice President, Finance | M 選擇權執行 | 8.5K | 12.50 | 107K | 23.9K | SEC |
| 2026-07-13 | 07-13 | Agarwal Arjun | Senior Vice President, Finance | M 選擇權執行 | 1.5K | 34.39 | 50K | 25.3K | SEC |
| 2026-07-13 | 07-13 | Agarwal Arjun | Senior Vice President, Finance | S 公開市場賣出(10b5-1) | 300 | 85.63 | 26K | 15.3K | SEC |
| 2026-07-13 | 07-13 | Agarwal Arjun | Senior Vice President, Finance | S 公開市場賣出(10b5-1) | 5.7K | 84.90 | 480K | 15.6K | SEC |
| 2026-07-13 | 07-13 | Agarwal Arjun | Senior Vice President, Finance | S 公開市場賣出(10b5-1) | 3.7K | 84.26 | 315K | 21.3K | SEC |
| 2026-07-13 | 07-13 | Agarwal Arjun | Senior Vice President, Finance | S 公開市場賣出(10b5-1) | 300 | 83.07 | 25K | 25.0K | SEC |
| 2026-07-01 | 07-01 | Fairmount Funds Management LLC | Director,TenPercentOwner | C 轉換 | 3.6M | – | – | 4.7M | SEC |
| 2026-07-01 | 07-01 | Fairmount Healthcare Fund II L.P. | Director,TenPercentOwner | S 公開市場賣出 | 3.6M | 84.43 | 300M | 1.1M | SEC |
| 2026-07-01 | 07-01 | Fairmount Healthcare Fund II L.P. | Director,TenPercentOwner | C 轉換 | 3.6M | – | – | 4.7M | SEC |
| 2026-07-01 | 07-01 | Harwin Peter Evan | Director,TenPercentOwner | S 公開市場賣出 | 3.6M | 84.43 | 300M | 1.1M | SEC |
| 2026-07-01 | 07-01 | Harwin Peter Evan | Director,TenPercentOwner | C 轉換 | 3.6M | – | – | 4.7M | SEC |
| 2026-07-01 | 07-01 | Sandler Laura Lee | Chief Operating Officer | S 公開市場賣出(10b5-1) | 500 | 95.47 | 48K | 236K | SEC |
| 2026-07-01 | 07-01 | Kiselak Tomas | Director,TenPercentOwner | C 轉換 | 3.6M | – | – | 4.7M | SEC |
| 2026-07-01 | 07-01 | Fairmount Funds Management LLC | Director,TenPercentOwner | S 公開市場賣出 | 3.6M | 84.43 | 300M | 1.1M | SEC |
| 2026-07-01 | 07-01 | Sandler Laura Lee | Chief Operating Officer | S 公開市場賣出(10b5-1) | 2.3K | 94.75 | 214K | 237K | SEC |
| 2026-07-01 | 07-01 | Sandler Laura Lee | Chief Operating Officer | S 公開市場賣出(10b5-1) | 2.2K | 93.85 | 210K | 239K | SEC |
| 2026-07-01 | 07-01 | Sandler Laura Lee | Chief Operating Officer | M 選擇權執行 | 5.0K | 7.80 | 39K | 241K | SEC |
| 2026-07-01 | 07-01 | Fairmount Healthcare Co-Invest III L.P. | Director,TenPercentOwner | S 公開市場賣出 | 3.6M | 84.43 | 300M | 1.1M | SEC |
| 2026-07-01 | 07-01 | Fairmount Healthcare Co-Invest III L.P. | Director,TenPercentOwner | C 轉換 | 3.6M | – | – | 4.7M | SEC |
| 2026-07-01 | 07-01 | Kiselak Tomas | Director,TenPercentOwner | S 公開市場賣出 | 3.6M | 84.43 | 300M | 1.1M | SEC |
| 2026-06-22 | 06-22 | Agarwal Arjun | Senior Vice President, Finance | S 公開市場賣出(10b5-1) | 699 | 82.15 | 57K | 15.3K | SEC |
| 2026-06-22 | 06-22 | Agarwal Arjun | Senior Vice President, Finance | S 公開市場賣出(10b5-1) | 888 | 80.01 | 71K | 16.0K | SEC |
| 2026-06-15 | 06-15 | Goncalves Joana | Chief Medical Officer | S 公開市場賣出(10b5-1) | 1.6K | 68.38 | 112K | 39.0K | SEC |
| 2026-06-15 | 06-15 | Goncalves Joana | Chief Medical Officer | M 選擇權執行 | 3.5K | 7.80 | 27K | 40.7K | SEC |
| 2026-06-15 | 06-15 | Goncalves Joana | Chief Medical Officer | M 選擇權執行 | 3.5K | 6.84 | 24K | 37.2K | SEC |
| 2026-06-15 | 06-15 | Klein Lawrence Otto | Chief Executive Officer | S 公開市場賣出 | 1.7K | 69.69 | 120K | 926K | SEC |
| 2026-06-15 | 06-15 | Sandler Laura Lee | Chief Operating Officer | S 公開市場賣出 | 600 | 69.69 | 42K | 236K | SEC |
| 2026-06-15 | 06-15 | Quinlan Paul T | General Counsel | S 公開市場賣出 | 733 | 69.69 | 51K | 31.0K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| FMR LLC | 9.1M | 862M | 新進 | 新進 |
| BlackRock, Inc. | 5.0M | 475M | 新進 | 新進 |
| Venrock Adviser, LLC | 4.1M | 395M | 新進 | 新進 |
| Fairmount Funds Management LLC | 3.7M | 353M | 新進 | 新進 |
| Capital World Investors | 3.4M | 324M | 新進 | 新進 |
| RTW INVESTMENTS, LP | 3.1M | 299M | 新進 | 新進 |
| STATE STREET CORP | 2.7M | 254M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.4M | 225M | 新進 | 新進 |
| Paradigm Biocapital Advisors LP | 2.1M | 204M | 新進 | 新進 |
| Deep Track Capital, LP | 1.9M | 183M | 新進 | 新進 |
| Bellevue Group AG | 1.7M | 158M | 新進 | 新進 |
| FRANKLIN RESOURCES INC | 1.6M | 154M | 新進 | 新進 |
| Remedium Capital Partners, LLC | 1.6M | 149M | 新進 | 新進 |
| RA CAPITAL MANAGEMENT, L.P. | 1.6M | 148M | 新進 | 新進 |
| 維京環球 VIKING GLOBAL INVESTORS LP | 1.5M | 143M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.4M | 136M | 新進 | 新進 |
| Jupiter Topco LLC | 1.4M | 131M | 新進 | 新進 |
| PERCEPTIVE ADVISORS LLC | 1.3M | 128M | 新進 | 新進 |
| Polar Capital Holdings Plc | 1.2M | 117M | 新進 | 新進 |
| 城堡 CITADEL ADVISORS LLC | 1.1M | 106M | 新進 | 新進 |
| BNP PARIBAS FINANCIAL MARKETS | 1.1M | 103M | 新進 | 新進 |
| Avidity Partners Management LP | 760K | 72.4M | 新進 | 新進 |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 658K | 62.7M | 新進 | 新進 |
| Aberdeen Group plc | 647K | 61.6M | 新進 | 新進 |
| UBS Group AG | 639K | 60.8M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 257 +73 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 257 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 74.1M · 100.0% |
| 合計季末市值 | 6.8B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 7.8M |
|---|---|
| 與上期比 | -6.1% |
| 佔流通股數 | 11.77% |
| 日均成交量 | 840K |
| 回補天數 | 9.3 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 7.8M | -6.1% | 11.77% | 840K | 9.3 |
| 2026-08-14 | 8.3M | +3.1% | 12.54% | 733K | 11.3 |
| 2026-07-31 | 8.1M | -8.8% | 12.16% | 961K | 8.4 |
| 2026-07-15 | 8.8M | -3.6% | 13.34% | 1.4M | 6.2 |
| 2026-06-30 | 9.2M | +32.8% | 13.84% | 2.1M | 4.3 |
| 2026-06-15 | 6.9M | +8.2% | 10.42% | 1.1M | 6.1 |
| 2026-05-29 | 6.4M | +1.9% | 9.63% | 1.3M | 5.0 |
| 2026-05-15 | 6.3M | -10.6% | 9.44% | 1.8M | 3.6 |
| 2026-04-30 | 7.0M | +26.3% | 10.56% | 2.7M | 2.6 |
| 2026-04-15 | 5.5M | +22.4% | 8.36% | 1.4M | 4.0 |
| 2026-03-31 | 4.5M | +24.1% | 6.83% | 901K | 5.0 |
| 2026-03-13 | 3.6M | -18.4% | 5.50% | 487K | 7.5 |
| 2026-02-27 | 4.5M | +9.9% | 6.75% | 286K | 15.6 |
| 2026-02-13 | 4.1M | -17.2% | 6.14% | 353K | 11.5 |
| 2026-01-30 | 4.9M | -6.4% | 7.41% | 553K | 8.9 |
| 2026-01-15 | 5.2M | -31.3% | 7.92% | 475K | 11.0 |
| 2025-12-31 | 7.6M | +30.8% | 11.52% | 904K | 8.4 |
| 2025-12-15 | 5.8M | +6.1% | 8.81% | 409K | 14.3 |
| 2025-11-28 | 5.5M | +4.7% | 8.30% | 419K | 13.1 |
| 2025-11-14 | 5.2M | +0.8% | 7.93% | 468K | 11.2 |
| 2025-10-31 | 5.2M | +30.3% | 7.87% | 301K | 17.3 |
| 2025-10-15 | 4.0M | +10.6% | 6.04% | 578K | 6.9 |
| 2025-09-30 | 3.6M | +17.8% | 5.46% | 731K | 4.9 |
| 2025-09-15 | 3.1M | -4.1% | 4.63% | 137K | 22.4 |
| 2025-08-29 | 3.2M | -25.7% | 4.83% | 136K | 23.6 |
| 2025-08-15 | 4.3M | +28.2% | 6.50% | 152K | 28.3 |